| 27.59 0.2 (0.73%) | 09-03 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 32.79 | 1-year : | 33.87 |
| Resists | First : | 28.08 | Second : | 29 |
| Pivot price | 27.41  |
|||
| Supports | First : | 26.59 | Second : | 22.12 |
| MAs | MA(5) : | 27.17 |
MA(20) : | 27.64 |
| MA(100) : | 26.07 |
MA(250) : | 24.26 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 26.2 |
D(3) : | 19.3 |
| RSI | RSI(14): 52.4 |
|||
| 52-week | High : | 30.42 | Low : | 18.77 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NVST ] has closed below upper band by 37.5%. Bollinger Bands are 50.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 28.31 - 28.42 | 28.42 - 28.53 |
| Low: | 26.92 - 27.05 | 27.05 - 27.17 |
| Close: | 27.39 - 27.59 | 27.59 - 27.77 |
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Thu, 03 Sep 2026
Envista Holdings stock rises on JPMorgan upgrade - Investing.com
Thu, 03 Sep 2026
Envista stock upgraded at J.P. Morgan (NVST:NYSE) - seekingalpha.com
Thu, 03 Sep 2026
JPMorgan Upgrades Envista to Overweight From Neutral, Lifts Price Target to $32 From $29 - marketscreener.com
Wed, 02 Sep 2026
symbol__ Stock Quote Price and Forecast - cnn.com
Mon, 24 Aug 2026
Do Options Traders Know Something About Envista Stock We Don't? - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 161 (M) |
| Shares Float | 160 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 120.9 (%) |
| Shares Short | 11,890 (K) |
| Shares Short P.Month | 9,840 (K) |
| EPS | 0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.15 |
| Profit Margin | 3.3 % |
| Operating Margin | 12.1 % |
| Return on Assets (ttm) | 3.3 % |
| Return on Equity (ttm) | 3 % |
| Qtrly Rev. Growth | 7 % |
| Gross Profit (p.s.) | 9.96 |
| Sales Per Share | 17.8 |
| EBITDA (p.s.) | 2.6 |
| Qtrly Earnings Growth | 111.3 % |
| Operating Cash Flow | 303 (M) |
| Levered Free Cash Flow | 276 (M) |
| PE Ratio | 47.56 |
| PEG Ratio | 0 |
| Price to Book value | 1.43 |
| Price to Sales | 1.54 |
| Price to Cash Flow | 14.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|